Xcout Intel
InSphero
InSphero provides 3D in vitro cell culture models, microplates, organ-on-a-chip platforms, and related services for drug discovery and safety testing. The company serves pharmaceutical, biotechnology, and research organizations seeking non-animal testing alternatives to evaluate drug efficacy, liver safety, oncology, and other complex diseases.
Subscribe to see InSphero’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
InSphero at a glance
InSphero is a biotech company headquartered in Switzerland. Xcout tracks 19 named people at InSphero, including Olivier Frey (Chief Operating Officer & Chief Technology Officer).
InSphero leadership
- Olivier FreyChief Operating Officer & Chief Technology Officer
- Julian von SeyfriedChief Financial Officer
- Madhu NagChief Scientific Officer
- Jan LichtenbergCEO and Co-Founder
- Wolfgang MoritzHead of External Collaborations, Co-founder
- Alexandra TitleVice President, Islet Biology
13 more named people on record for InSphero, with roles, board committees and tenure — see the full roster →
InSphero competitors
A few of InSphero's closest competitors — see the full list of competitors and alternatives →
Hubrecht Organoid Technology (HUB) develops patented patient-derived organoid technology from healthy and diseased tissues to predict patient responses to treatments. The company functions as a contract research organization (CRO), offering drug discovery services, custom model and assay development, clinical trials in a dish, and licensing programs for pharmaceutical and research applications.
genOway provides preclinical models and custom research solutions, including genetically modified mice, rats, and cell lines, to biopharmaceutical and academic researchers. The company specializes in creating tools such as humanized and conditional knockout models to support efficacy, safety, and pharmacokinetic assessments in drug discovery.
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
BICO provides lab automation software, instruments, biomaterials, and liquid handling solutions for life science research, drug discovery, and tissue engineering. The company serves pharmaceutical companies, biotechnology firms, and academic institutions by automating laboratory workflows and providing 3D bioprinting and imaging technologies.
Axol Bioscience is a leading provider of iPSC-derived cells and related services, supporting neuroscience, ophthalmology, and cardiotoxicity drug discovery with advanced human disease models.
Emulate, Inc. (Emulate) is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, testing how different medicines, chemicals, and foods affect human health. Emulate has also worked with Cedars-Sinai Medical Center on a precision medicine initiative that uses Organs-on-Chips technology in the clinical setting. This initiative is designed to provide clinicians with better data about how a
Get InSphero's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on InSphero in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access